메뉴 건너뛰기




Volumn 93, Issue 7, 2004, Pages 914-915

Two-drug therapy is best for symptomatic prostate enlargement: Could a combination of doxazosin and finasteride change clinical practice?

Author keywords

[No Author keywords available]

Indexed keywords

DOXAZOSIN; FINASTERIDE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ENZYME INHIBITOR;

EID: 2542583105     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410x.2004.04799.x     Document Type: Conference Paper
Times cited : (2)

References (12)
  • 1
    • 0024551135 scopus 로고
    • Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients
    • Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989; 141: 243.
    • (1989) J Urol , vol.141 , pp. 243
    • Mebust, W.K.1    Holtgrewe, H.L.2    Cockett, A.T.K.3    Peters, P.C.4
  • 2
    • 0029939081 scopus 로고    scopus 로고
    • The Hytrin Community Assessment Trial study: A one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia
    • Roehrborn CG, Oesterling JE, Auerbach S et al. The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. Urology 1996; 47: 159-68
    • (1996) Urology , vol.47 , pp. 159-168
    • Roehrborn, C.G.1    Oesterling, J.E.2    Auerbach, S.3
  • 3
    • 0030248565 scopus 로고    scopus 로고
    • Safety and efficacy of doxazosin in benign prostatic hyperplasia: Apooled analysis of three double-blind, placebo-controlled studies
    • Roehrborn CG, Siegel RL. Safety and efficacy of doxazosin in benign prostatic hyperplasia: apooled analysis of three double-blind, placebo-controlled studies. Urology 1996; 48: 406-15
    • (1996) Urology , vol.48 , pp. 406-415
    • Roehrborn, C.G.1    Siegel, R.L.2
  • 4
    • 0029034556 scopus 로고
    • Efficacy and safety of tamsulosin in the treatment of benign prostatic hyperplasia
    • Kawabe K. Efficacy and safety of tamsulosin in the treatment of benign prostatic hyperplasia. Br J Urol 1995; 76: 63-7
    • (1995) Br J Urol , vol.76 , pp. 63-67
    • Kawabe, K.1
  • 5
    • 0035667615 scopus 로고    scopus 로고
    • Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: A randomized, placebo-controlled trial
    • Roehrborn CG. Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a randomized, placebo-controlled trial. Urology 2001; 58: 953-9
    • (2001) Urology , vol.58 , pp. 953-959
    • Roehrborn, C.G.1
  • 6
    • 9444268678 scopus 로고    scopus 로고
    • The efficacy of terazosin, finasteride or both in benign prostatic hyperplasia
    • Lepor H, Williford WO, Barry MJ et al. The efficacy of terazosin, finasteride or both in benign prostatic hyperplasia. N Engl J Med 1996; 335: 533-9
    • (1996) N Engl J Med , vol.335 , pp. 533-539
    • Lepor, H.1    Williford, W.O.2    Barry, M.J.3
  • 7
    • 0037253614 scopus 로고    scopus 로고
    • Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: The Prospective European Doxazosin and Combination Therapy (PREDICT) trial
    • Kirby RS, Roehrborn C, Boyle P et al. Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial. Urology2003; 61: 119-26
    • (2003) Urology , vol.61 , pp. 119-126
    • Kirby, R.S.1    Roehrborn, C.2    Boyle, P.3
  • 8
    • 0347882750 scopus 로고    scopus 로고
    • The long-term effect of doxazosin, finasteride and combination therapy on the clinical progression of benign prostatic hyperplasia
    • McConnell JD, Roehrborn CG, Bautista OM et al. The long-term effect of doxazosin, finasteride and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003; 349: 2387-98
    • (2003) N Engl J Med , vol.349 , pp. 2387-2398
    • McConnell, J.D.1    Roehrborn, C.G.2    Bautista, O.M.3
  • 9
    • 0036754256 scopus 로고    scopus 로고
    • Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia
    • Roehrborn CG, Boyle P, Nickel JC et al. Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology, 2002; 60: 434-41
    • (2002) Urology , vol.60 , pp. 434-441
    • Roehrborn, C.G.1    Boyle, P.2    Nickel, J.C.3
  • 10
    • 0342618512 scopus 로고    scopus 로고
    • Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia
    • Andersen JT, Nickel JC, Marshall VR et al. Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia. Urology 1997; 49: 839-45
    • (1997) Urology , vol.49 , pp. 839-845
    • Andersen, J.T.1    Nickel, J.C.2    Marshall, V.R.3
  • 11
    • 0029024794 scopus 로고
    • The Agency for Healthcare Policy and Research. Clinical Guidelines for the diagnosis and treatment of benign prostatic hyperplasia
    • Roehrborn CG. The Agency for Healthcare Policy and Research. Clinical Guidelines for the diagnosis and treatment of benign prostatic hyperplasia. Urol Clin North Am 1995; 22: 445-53
    • (1995) Urol Clin North Am , vol.22 , pp. 445-453
    • Roehrborn, C.G.1
  • 12
    • 2542642296 scopus 로고    scopus 로고
    • Guideline for the primary care management of male lower urinary tract symptoms
    • in press
    • Speakman MJ, Kirby RS, Joyce A et al. Guideline for the primary care management of male lower urinary tract symptoms. BJU Int 2004; 93: in press
    • (2004) BJU Int , vol.93
    • Speakman, M.J.1    Kirby, R.S.2    Joyce, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.